The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multiple chemotherapy (CT) lines in metastatic breast cancer (MBC): Which survival benefit for women with hormone receptor (HR)-positive disease?
Raffaella Palumbo
No relevant relationships to disclose
Antonio Bernardo
No relevant relationships to disclose
Alberto Riccardi
No relevant relationships to disclose
Federico Sottotetti
No relevant relationships to disclose
Cristina Teragni
No relevant relationships to disclose
Giovanni Bernardo
No relevant relationships to disclose